Find investors
← Back to all investors
Cole Michalek
ResearchedAngel Investors

Cole Michalek

Associate

Angel InvestorsSeed Round
Pitch Cole

Get their honest, personalized take on your startup.

Sign in to pitch Cole

At a glance

Full Name
Cole Michalek
Title
Vice President / Investment Professional ("Partners with Operating Experience") — *previously Vice President, Shore Capital Partners*
Firm
Talisman Capital Partners (current) — *formerly Shore Capital Partners*
Firm Type
Private investment company / single-family office (the Walter family) — *Shore is a microcap private equity firm*
Investment Stage
Established / lower-middle-market and middle-market companies (control and non-control equity, special situations) — *not seed/angel, despite the stub's "Angel Investors / Seed Round" label, which appears to be inaccurate aggregator data*
Check Size
Talisman typically deploys $10–25M initially, up to ~$100M per opportunity; Shore targets companies with $1–10M of EBITDA
Target Company Profile
Profitable, established businesses with strong management teams where the investor can add operational value
Sector Focus
At Talisman — broad/sector-agnostic, with activity in healthcare, financial services, manufacturing, software, B2B/B2C and IT; at Shore — healthcare, food & beverage, business services, and real estate (Cole supported Shore's Real Estate platform)
Geographic Focus
United States
Location
Columbus, Ohio (Talisman) — *previously Chicago, Illinois (Shore)*

Background

Cole Michalek is an investment professional who, as of January 2025, joined Talisman Capital Partners, the Columbus, Ohio–based private investment company of the Walter family. Talisman lists him among its "Partners with Operating Experience," where his work centers on private equity and private debt investments — conducting due diligence on new opportunities and helping implement value-creation initiatives across portfolio companies.

He spent roughly six years at Shore Capital Partners, a Chicago-based microcap private equity firm focused on companies with $1–10M of EBITDA across healthcare, food & beverage, business services, and real estate. Cole progressed from Associate to Senior Associate to Vice President (he held the VP role from approximately January 2023 to January 2025). At Shore he was responsible for due diligence on new investments and value-creation work within the portfolio, and notably supported Partner Steve Malley on Shore's Real Estate platform, which partners with entrepreneurs and operators at microcap real estate companies.

Cole began his career in investment banking, joining Wells Fargo Securities' Investment Banking Division as an analyst around January 2016, where he advised on mergers and acquisitions, leveraged buyouts, and debt and equity financings. Earlier, he completed internships at VMG Health and Pearigee Partners.

He earned a B.S. in Economics (and Finance) from Southern Methodist University.

Investment Thesis & Focus

  • Stage / type: Established, profitable companies rather than early-stage venture — control equity, non-control (minority) equity, and mezzanine/private debt. (The stub's "angel / seed" framing does not match his actual private-equity career.)
  • Check size: At Talisman, initial investments of roughly $10–25M, scaling to as much as $100M per opportunity; at Shore, microcap deals in the $1–10M EBITDA range.
  • What makes them say yes (firm thesis): Talisman invests its own capital only — no outside LPs, no fee streams, and no "artificial, finite holding periods," prioritizing long-term value creation in partnership with strong management teams. They look for situations where they "can leverage our experience as entrepreneurs and operators."
  • Sectors: Talisman is largely sector-agnostic ("open to opportunities in nearly all industries"), with demonstrated interest in healthcare, financial services, manufacturing, software, and technology. Cole's Shore experience adds depth in healthcare, business services, food & beverage, and real estate.
  • Operating orientation: Cole's role emphasizes hands-on diligence and post-close value creation, consistent with an operator-led, build-businesses approach rather than passive financial investing.

Notable Investments

  • Bond Vet — modern veterinary care chain; Talisman participated in a $50M Series B round on Oct 16, 2023 (alongside Warburg Pincus).
  • Prilenia Therapeutics — clinical-stage neurology/drug-discovery biotech in Talisman's portfolio.
  • R1 RCM — healthcare revenue-cycle management company associated with Talisman's portfolio.
  • Shore Capital Real Estate platform — Cole supported Partner Steve Malley on Shore's microcap real-estate investing vehicle, partnering with operators and entrepreneurs across the real estate industry.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.